Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 6—June 2003

Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia1

Mitchell J. Schwaber*†‡Comments to Author , Sharon B. Wright*†, Yehuda Carmeli*†‡, Lata Venkataraman*†, Paola C. DeGirolami*†, Aneta Gramatikova§, Trish M. Perl§, George Sakoulas*†, and Howard S. Gold*†
Author affiliations: *Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; †Harvard Medical School, Boston, Massachusetts, USA; ‡Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; §Johns Hopkins Hospital, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA

Main Article

Table 1

Strain typing and relationship to reduced vancomycin susceptibility screening results

No. isolates Positive results on screening Odds ratio (95% confidence interval) p
Type A
34 (33%)
0.35 (0.17 to 0.71)
Type B
16 (73%)
4.86 (1.87 to 13.29)
Other type 24 11 (46) - -

Main Article

1Presented in part at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, December 2001.

Page created: December 22, 2010
Page updated: May 30, 2012
Page reviewed: May 30, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.